G. Wilson

Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer

Marc Peeters, Timothy Price, Andrés Cervantes et al. · Journal of Clinical Oncology · 2010 · 992 citations

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial

Andrew Tutt, Holly Tovey, Maggie C.U. Cheang et al. · Nature Medicine · 2018 · 862 citations · Full text

Tnt Trial, Breast Oncology, Medicine +7

Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer

Alison Clayton, Sarah Danson, Sanjay Jolly et al. · British Journal of Cancer · 2004 · 385 citations · Full text

Final results from a randomized phase 3 study of FOLFIRI ± panitumumab for second-line treatment of metastatic colorectal cancer

Marc Peeters, Timothy Price, Andrés Cervantes et al. · Annals of Oncology · 2013 · 219 citations · Full text

Gastrointestinal Oncology, Medicine, Pharmacology +9

Analysis of <i>KRAS</i> / <i>NRAS</i> Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer

Marc Peeters, Kelly S. Oliner, Timothy Price et al. · Clinical Cancer Research · 2015 · 179 citations · Full text